OTCMKTS:RCDTF Recordati Industria Chimica e Farmaceutica (RCDTF) Stock Price, News & Analysis $51.60 0.00 (0.00%) (As of 07/25/2024 ET) Add Compare Share Share Today's Range$51.60▼$51.6050-Day Range$51.60▼$51.6052-Week Range$51.60▼$51.98Volume1,250 shsAverage Volume31 shsMarket CapitalizationN/AP/E Ratio18.63Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get Recordati Industria Chimica e Farmaceutica alerts: Email Address Ad Monument Traders AllianceThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.See here to see the full details. About Recordati Industria Chimica e Farmaceutica Stock (OTCMKTS:RCDTF)Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis. The company also develops CARBAGLU for hyperammonemia due to NAGS deficiency; QARZIBA, an apeiron for the treatment of high-risk neuroblastoma patients with a partial response at the chemotherapeutical through myeloablative therapy and stem cell transplantation, and relapsed or refractory neuroblastoma. In addition, it offers SYLVANT for the treatment of idiopathic multicentric Castleman diseases; REAGILA for Schizophrenia; and ELIGARD for hormone-dependent prostate cancer, as well as CAPHOSOL, a medical device for treatment of oral mucositis due to chemo and radiation therapy. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.Read More RCDTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCDTF Stock News HeadlinesJuly 20, 2024 | markets.businessinsider.comKepler Capital Sticks to Their Hold Rating for Recordati Industria Chimica e Farmaceutica SPA (0KBS)July 16, 2024 | americanbankingnews.comShort Interest in Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Rises By 19.1%July 26, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.May 8, 2024 | markets.businessinsider.comHere's what to expect from Recordati Industria Chimica e Farmaceutica SPAAz Post raggruppamento's earningsApril 24, 2024 | msn.comBorsa: Milano fiacca con Recordati e Saipem, vola StmApril 23, 2024 | msn.comCVC explores options for Italy's Recordati, Bloomberg News reportsApril 23, 2024 | finance.yahoo.comCVC Explores Options for €11 Billion Drugmaker RecordatiApril 23, 2024 | finance.yahoo.comUPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reportsJuly 26, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.March 19, 2024 | msn.comFarmaceutica, le big si muovono: Astrazeneca acquista, Pfizer vende. Da Recordati cedola maggiorata con un occhio alle opportunitàDecember 29, 2023 | msn.comBorsa Milano, lieve rialzo (+0,07%), Recordati e banche in rialzoDecember 19, 2023 | seekingalpha.comRICFY Recordati Industria Chimica e Farmaceutica S.p.A.November 7, 2023 | msn.comItaly's Recordati sees 2023 results at top end of the rangeNovember 7, 2023 | uk.news.yahoo.comItaly's Recordati nudges up 2023 guidance as 9-mth revenue, profit jumpsSeptember 9, 2023 | forbes.comFondo pensione: cos’è e come funzionaJuly 21, 2023 | msn.comBorsa: Milano positiva con le banche, vola RecordatiMay 12, 2023 | msn.comItaly's Recordati boosted by strong sales in RussiaMay 11, 2023 | msn.comRecordati GAAP EPS of €0.59, revenue of €551.4MSee More Headlines Receive RCDTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Recordati Industria Chimica e Farmaceutica and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:RCDTF Previous SymbolNASDAQ:RCDTF CUSIPN/A CIKN/A Webwww.recordati.com Phone390-248-7871Fax39-02-4007-3747Employees4,369Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio18.63 Forward P/E Ratio18.36 P/E GrowthN/ANet Income$421.25 million Net Margins18.18% Pretax Margin23.58% Return on Equity30.58% Return on Assets12.57% Debt Debt-to-Equity Ratio0.73 Current Ratio1.36 Quick Ratio0.95 Sales & Book Value Annual Sales$2.25 billion Price / SalesN/A Cash Flow$3.06 per share Price / Cash Flow16.86 Book Value$7.90 per share Price / Book6.53Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.33 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesDr. Robert Koremans M.D. (Age 62)CEO & Director Comp: $1.94MMr. Luigi Felice La Corte (Age 55)Group CFO & Executive Director Comp: $1.02MMs. Cathrin Petty (Age 51)Executive Director Mr. Giampiero Mazza (Age 55)Executive Director Mr. Giorgio De Palma (Age 50)Executive Director Ms. Eugenia LitzVP & Head of Investor RelationsMs. Bibianne BonGroup Chief Legal OfficerMs. Laura ContiGroup Communications DirectorMr. Gabriele FinziExecutive VP of Corporate Development, Licensing & InnovationMs. Alessandra AbateGroup Chief People & Culture OfficerMore ExecutivesKey CompetitorsAisinOTCMKTS:ASEKYAllkemOTCMKTS:OROCFAmadeus IT GroupOTCMKTS:AMADYANAOTCMKTS:ALNPYAndritzOTCMKTS:ADRZYView All Competitors RCDTF Stock Analysis - Frequently Asked Questions How have RCDTF shares performed this year? Recordati Industria Chimica e Farmaceutica's stock was trading at $46.00 at the start of the year. Since then, RCDTF stock has increased by 12.2% and is now trading at $51.60. View the best growth stocks for 2024 here. How were Recordati Industria Chimica e Farmaceutica's earnings last quarter? Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) issued its earnings results on Thursday, May, 9th. The company reported $0.85 earnings per share (EPS) for the quarter. The firm had revenue of $659.94 million for the quarter. Recordati Industria Chimica e Farmaceutica had a trailing twelve-month return on equity of 30.58% and a net margin of 18.18%. How do I buy shares of Recordati Industria Chimica e Farmaceutica? Shares of RCDTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RCDTF) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recordati Industria Chimica e Farmaceutica S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recordati Industria Chimica e Farmaceutica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCDTF Stock Alerts